Skip to content

Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in End Stage Renal Disease (ESRD)

A Case Controlled Study to Determine the Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in ESRD

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01017627
Enrollment
1500
Registered
2009-11-20
Start date
2009-11-30
Completion date
2010-12-31
Last updated
2010-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Mortality

Keywords

ESRD, Anemia, Hospitalizations, Mortality

Brief summary

The investigators hypothesize that the post-hospitalized patient status is characterized by subacute and reversible metabolic and hematological changes that, if addressed and treated in a timely manner, would result in a reduced risk for repeat hospitalization. Consequently, a structured quality improvement program, focused on increasing adherence to company wide anemia management policies (ie hemoglobin monitoring within the first 3-5 days post-hospitalization, followed by an appropriate EPO dose modification within the 7 days post-hospitalization), will significantly decrease the risk of hospital re-admission in the 30 days after discharge.

Detailed description

The post-hospitalization quality improvement project will be piloted across 30 Fresenius clinics. Targeted enrollment of 1500 episodes of hospitalization in which the patient returns after discharge to resume outpatient dialysis. Patient outcomes will be followed for up to 30 days from the time of discharge from hospital.

Interventions

OTHEREarly anemia diagnosis and treatment

Patients returning to the unit are immediately assessed and treated for anemia

OTHERNo change from normal routine

Normal unit policy for labs and anemia treatment

Sponsors

Fresenius Medical Care North America
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age ≥ 18 * resumption of routine outpatient chronic hemodialysis within three days of discharge from hospital admission * enrolled in a facility-based anemia management program

Exclusion criteria

* enrolled in hospice * previous hospitalization within the past 30 days (ie. patients discharged from a repeat hospitalization) * anticipated discharge from the outpatient dialysis facility within 30 days (ie anticipated transfer to another facility or hospice)

Design outcomes

Primary

MeasureTime frame
composite of death or repeat hospitalization within the 30 days after discharge from a previous hospitalizationone year to accumulate 1500 hospitalizations

Secondary

MeasureTime frame
hemoglobin, transferrin saturation, albumin, white blood cell count, and C-reactive protein* levels measured in the period following hospitalization and change relative to values measured prior to hospitalization (where available).one year to accumulate 1500 hospitalizations

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026